Q2 earnings and buybacks put Cigna Group in focus Cigna Group (CI) is back on investors’ radar after reporting its second ...

Cigna Group is transitioning its pharmacy benefits business to a rebate-free model under its new CEO, Brian Evanko.

July 30 (Reuters) - Cigna on Thursday raised its annual profit forecast, after beating quarterly earnings estimates on growth ...

Dr. Stanley Crittenden, CMO of Cigna Healthcare, discusses how AI is transforming customers' lives through the company's ...

Cigna increased its 2026 earnings outlook following the second quarter, unbothered by inflated costs for surprise billing ...

The Cigna Group reported second quarter net income of nearly $1.7 billion despite continued elevated medical costs dogging ...

When digital musculoskeletal company Hinge Health launched about a decade ago, it primarily targeted employers directly. However, in recent years, it has expanded its health plan partnerships and is ...

July 1 (Reuters) - Cigna (CI.N), opens new tab said on Wednesday its health services unit Evernorth has launched a new AI-powered specialty pharmacy program to reduce the time ‌it takes to process ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Cigna Group plans to exit the individual health insurance business also known as ...

NEW YORK, June 2 (Reuters) - Health insurer Cigna (CI.N), opens new tab will stop covering GLP-1 weight-loss drugs including Novo Nordisk's (NOVOb.CO), opens new tab Wegovy and Eli Lilly's (LLY.N), ...

Cigna maintains a Buy rating as valuation remains deeply discounted despite steady earnings growth and raised guidance. Click here to read more on CI stock.